Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
Biotechniques
|
May 10, 2011
Use of a negative selectable marker for rapid selection of recombinant vaccinia virus
Stacy D White, Kip Conwell, Jeffrey O Langland, et al.
Journal of Virology
|
January 1, 2010
Evidence for multiple recent host species shifts among the Ranaviruses (family Iridoviridae)
James K Jancovich, Michel Bremont, Jeffrey W Touchman, et al.
Journal of Virology
|
March 27, 2009
Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L
Ping Zhang, Jeffrey O Langland, Bertram L Jacobs, et al.
Journal of Virology
|
December 22, 2006
Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist
Ye Ye, Kevin Hauns, Jeffrey O Langland, et al.
Plos One
|
September 15, 2010
Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals
Karen L Denzler, Robert Waters, Bertram L Jacobs, et al.
Protein Science : a Publication of the Protein Society
|
August 3, 2013
A leader sequence capable of enhancing RNA expression and protein synthesis in mammalian cells
Brian P Wellensiek, Andrew C Larsen, Julia Flores, et al.
Biomedicines
|
February 25, 2022
Small Hero with Great Powers: Vaccinia Virus E3 Protein and Evasion of the Type I IFN Response
Mateusz Szczerba, Sambhavi Subramanian, Kelly Trainor, et al.
Virus Research
|
May 18, 2006
Inhibition of PKR by RNA and DNA viruses
Jeffrey O Langland, Jason M Cameron, Michael C Heck, et al.
Journal of HIV/AIDS & Social Services
|
September 24, 2013
Effects of an undergraduate HIV/AIDS course on students' HIV risk
Flavio F Marsiglia, Bertram L Jacobs, Tanya Nieri, et al.
Virology
|
February 22, 2005
The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response
Teresa Brandt, Michael C Heck, Sangeetha Vijaysri, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
Biotechniques
|
May 10, 2011
Use of a negative selectable marker for rapid selection of recombinant vaccinia virus
Stacy D White, Kip Conwell, Jeffrey O Langland, et al.
Journal of Virology
|
January 1, 2010
Evidence for multiple recent host species shifts among the Ranaviruses (family Iridoviridae)
James K Jancovich, Michel Bremont, Jeffrey W Touchman, et al.
Journal of Virology
|
March 27, 2009
Protein kinase PKR-dependent activation of mitogen-activated protein kinases occurs through mitochondrial adapter IPS-1 and is antagonized by vaccinia virus E3L
Ping Zhang, Jeffrey O Langland, Bertram L Jacobs, et al.
Journal of Virology
|
December 22, 2006
Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist
Ye Ye, Kevin Hauns, Jeffrey O Langland, et al.
Plos One
|
September 15, 2010
Regulation of inflammatory gene expression in PBMCs by immunostimulatory botanicals
Karen L Denzler, Robert Waters, Bertram L Jacobs, et al.
Protein Science : a Publication of the Protein Society
|
August 3, 2013
A leader sequence capable of enhancing RNA expression and protein synthesis in mammalian cells
Brian P Wellensiek, Andrew C Larsen, Julia Flores, et al.
Biomedicines
|
February 25, 2022
Small Hero with Great Powers: Vaccinia Virus E3 Protein and Evasion of the Type I IFN Response
Mateusz Szczerba, Sambhavi Subramanian, Kelly Trainor, et al.
Virus Research
|
May 18, 2006
Inhibition of PKR by RNA and DNA viruses
Jeffrey O Langland, Jason M Cameron, Michael C Heck, et al.
Journal of HIV/AIDS & Social Services
|
September 24, 2013
Effects of an undergraduate HIV/AIDS course on students' HIV risk
Flavio F Marsiglia, Bertram L Jacobs, Tanya Nieri, et al.
Virology
|
February 22, 2005
The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response
Teresa Brandt, Michael C Heck, Sangeetha Vijaysri, et al.
Page
of 6